Drugs / Eupatilin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04885751 | Jun → Dec 2021 | ankylosing spondylitis, enteritis, gastric ulcer, osteoarthritis | Seoul National University Boramae Hospital | Unknown | No outcome recorded |
News releases announcing trial results or a regulatory action · 1
| Date | Issuer | Release |
|---|---|---|
| 2002-10-31 | Dong-A ST Co., Ltd. | Results Best Paper at United European Gastroenterology Week donga-st.com ↗
The papers dealt with “Phase III Clinical Trial of Stillen®, a new drug containing Eupatilin, as a treatment for chronic/Acute Gastritis.” |
All press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2002-10-31 | Dong-A ST Co., Ltd. | Best Paper at United European Gastroenterology Week donga-st.com ↗ |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Eupatilin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04885751 ↗ |
| Known as | NSC-122413 | ChEMBL registry synonym — accepted as the source's own label CHEMBL312750 ↗ |
| Modality | Small molecule | — CHEMBL312750 ↗ |